Evidence map›Paper›PMID 30670101›Full record

ArticleStem cell research & therapy2019

Stem cells from human exfoliated deciduous teeth correct the immune imbalance of allergic rhinitis via Treg cells in vivo and in vitro.

Yu-Yang Dai, Si-Yang Ni, Ke Ma, Yu-Shi Ma, Zhi-Shi Wang, Xiu-Li Zhao

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. [Research advances of mesenchymal stem cell in allergic rhinitis].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yu-Yang DaiNational Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, 1 Dongjiaominxiang Road, Beijing, 100730, China.
Si-Yang NiNational Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, 1 Dongjiaominxiang Road, Beijing, 100730, China.
Ke MaBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, 9 Chongwenmennei Road, Beijing, 100005, China.
Yu-Shi MaBeijing Tason Biotech Co. Ltd., 10 PKUCare Industrial Park, Beijing, 102206, China.
Zhi-Shi WangBeijing Tason Biotech Co. Ltd., 10 PKUCare Industrial Park, Beijing, 102206, China.
Xiu-Li ZhaoNational Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, 1 Dongjiaominxiang Road, Beijing, 100730, China. lilyzhao1028@outlook.com.ORCID 0000-0002-9202-6181
Beijing Tongren Hospital · CNSinovac Biotech · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral studies have demonstrated that mesenchymal stem cells can ameliorate the inflammation of allergic rhinitis (AR) and correct the Th1/Th2 immune imbalance.

methodsThis study was performed to explore the immunomodulation properties of stem cells from human exfoliated deciduous teeth (SHEDs) in the treatment of AR in vivo and in vitro. BALB/c mice were sensitized to ovalbumin (OVA) by intraperitoneal injection, and then SHEDs or bone marrow mesenchymal stem cells (BMMSCs) were injected intravenously before challenge. We evaluated nasal symptoms, inflammatory infiltration of nasal mucosa, immunoglobulin secretion, cytokine production, and mRNA expression in the spleen. In addition, peripheral blood mononuclear cells (PBMCs) from AR patients were cultured with SHEDs or BMMSCs in the presence of phytohemagglutinin (PHA). PBMCs cultured alone with or without PHA served as controls. After 3 days of culture, we examined the effect of SHEDs on T lymphocyte proliferation, cytokine secretion, and the proportion of Foxp3

resultsNasal symptoms and inflammatory infiltration were significantly reduced after SHED administration. The OVA-specific IgE and IgG

conclusionThese results suggest that SHEDs could correct the CD4

Indexed as

AnimalsDisease Models, AnimalFemaleHumansMesenchymal Stem CellsMiceRhinitis, AllergicT-Lymphocytes, RegulatoryTooth, DeciduousAllergic rhinitisImmunoregulationRegulatory T cellsStem cells from human exfoliated deciduous teethTransforming growth factor beta

Identifiers

PMID30670101
PMCPMC6341645
OpenAlexW2916832663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.